Stoneham, MA, United States of America

Thompson Jeffrey

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Apoxis S.a., Biogen Idec Ma Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thompson Jeffrey. Retrieved from https://idiyas.com/inventor/thompson-jeffrey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Thompson Jeffrey

Introduction

Thompson Jeffrey is a notable inventor based in Stoneham, MA (US). He has made significant contributions to the field of immunology, particularly with his work on the BAFF receptor. His innovative approach has led to advancements in understanding immunoregulatory agents.

Latest Patents

Thompson Jeffrey holds 1 patent for the BAFF receptor (BCMA), which is a novel receptor in the TNF family. This patent includes chimeric molecules and antibodies to BAFF-R, along with methods of use for these innovations. His work has the potential to impact therapeutic strategies in immunology.

Career Highlights

Throughout his career, Thompson Jeffrey has worked with prominent companies such as Biogen Idec MA Inc. and Apoxis S.A. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Browning Jeffrey and Ambrose Christine. Their collaborative efforts have furthered the research and development of immunoregulatory agents.

Conclusion

Thompson Jeffrey's contributions to the field of immunology through his innovative work on the BAFF receptor highlight his importance as an inventor. His patents and collaborations reflect a commitment to advancing scientific knowledge and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…